ResearcherKyoto UniversityNo recent work listed
Hiroto Nishino
Matched on ORCID iD 0000-0002-7377-9997; OpenAlex author ID A5010555884. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers
Papers 6
- Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse … Co-author DOI 10.1245/s10434-022-12466-4↗
- Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study. Co-author DOI 10.3390/jpm13050857↗
- Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft. Co-author DOI 10.21873/invivo.12676↗
- Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. Co-author DOI 10.3390/biom12050711↗
- Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model. Co-author DOI 10.1097/mpa.0000000000001709↗
- Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse… Co-author DOI 10.1016/j.canlet.2020.07.034↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael Bouvet · 6 shared papers, 2020–2023 · strength 0.88
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
- Robert M. Hoffman · 6 shared papers, 2020–2023 · strength 0.88
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
- Michael A. Turner · 4 shared papers, 2022–2023 · strength 0.67
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
- Thinzar Min Lwin · 3 shared papers, 2022–2023 · strength 0.51
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft. DOI 10.21873/invivo.12676↗
- Surinder K. Batra · 2 shared papers, 2022–2023 · strength 0.30
- Kavita B. Mallya · 2 shared papers, 2022–2023 · strength 0.30
- Norihiko Sugisawa · 2 shared papers, 2020–2021 · strength 0.21
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with ag… DOI 10.1016/j.canlet.2020.07.034↗
- Jun Yamamoto · 2 shared papers, 2020–2021 · strength 0.21
- Paper Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient… DOI 10.1097/mpa.0000000000001709↗
- Paper Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with ag… DOI 10.1016/j.canlet.2020.07.034↗
- Kristin E. Cox · 1 shared paper, 2023 · strength 0.16
- Aaron M. Mohs · 1 shared paper, 2023 · strength 0.16
- Andrew M. Lowy · 1 shared paper, 2022 · strength 0.14
- Sukhwinder Kaur · 1 shared paper, 2022 · strength 0.14
- Kei Kawaguchi · 1 shared paper, 2021 · strength 0.12
- Michiaki Unno · 1 shared paper, 2021 · strength 0.12
- Yuki Homma · 1 shared paper, 2020 · strength 0.09
- Kentaro Miyake · 1 shared paper, 2020 · strength 0.09
- Sant P. Chawla · 1 shared paper, 2020 · strength 0.09
- Itaru Endo · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.